The role of tumor necrosis factor and interleukin-6 in polycystic ovary syndrome;Rola czynnika martwicy nowotworów i interleukiny-6 w zespole policystycznych jajników

Polski Merkuriusz Lekarski

Volumn 21, Issue 125, 2006, Pages 489-491

  Banaś, Michał ^a   Olszanecka Glinianowicz, Magdalena ^a,b   Zahorska Markiewicz, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Katedra Patofizjologii   (Poland)

Author keywords

Interleukin 6; Policystic ovary syndrome; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; MEDICAL LITERATURE; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; REVIEW;

FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; OBESITY; POLYCYSTIC OVARY SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845344344     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Amato G., Conte M., Mazziotti G. i wsp.: Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet. Gynecol., 2003, 101, 1177-1182.
2. Chin D., Shacleton C., Prasad V.K.i wsp.: Increased 5alpha - reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism and C19 and C21 steroids in a young population with polycystic ovary syndrome. J. Pediatr. Endocrinol. Metab., 2001, 13, 253-259.
3. Dunaif A.: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol. Rev., 1997, 18, 774-800.
4. Fresno M., Kopf M., Rivas L.: Cytokines and infectious diseases. Immunol. Today, 1997, 18, 56-58.
5. Gadient R., Patterson P.: Leukemia inhibitory factor, interleukin-6 and other cytokines using the GP 130 transducing receptor: roles in inflammation and injury. Stem. Cells., 1999, 17, 127-137.
6. Grotowski W.: Wpływ TNF-α na proces apoptozy komórek ziarnistych w zespole policystycznych jajników. Ginekol. Prakt., 2001, 9, 76-79.
7. Heller R., Kronke M.: Tumor necrosis factor receptor-mediated signaling pathways. Cells. Biol., 1994, 126, 5-9.
8. Jacobs H.S.: Insulin like growth factor receptor. In: Insulin Springer - Verlak, New York 1990, 269.
9. Kowalska I., Stra̧czkowski M., Kinalska I. i wsp.: Uklad TNF-α u otyłych pacjentek z zespołem policystycznych jajników. Endokr. Pol. 2002, 53, supl. 1, 53.
10. Kowalski J., Labuzek K., Herman Z.: Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells. Neurochem. Int., 2003, 43, 173-178.
11. Kras K., Hausman D., Martin R.: Tumor necrosis factor-a stimulates cell proliferation in adipose tissue - derived stromal - vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors. Obes. Res., 2000, 8, 186-193.
12. Kroder G., Bossenmaier B., Kellerer M. i wsp.: Tumor necrosis factor-a and hyperglycemia - induced insulin resistance. evidence for different mechanisms and different effects on insulin signaling. J. Clin. Invest., 1996, 97, 1471-1477.
13. Mandrup-Poulsen T., Nerup J., Reimers J. i wsp., Cytokines and the endocrine system. The immunoendocrine network. Eur. J. Endocrinol., 1995, 133, 660-671.
14. Mantzoros C., Moschos S., Avramopoulos I. i wsp.: Leptin concentrations in relation to body mass index and the tumor necrosis factor-a system in humans. J. Clin. Endocrinol. Metab., 1997, 82, 3408-3413.
15. Marfella R., Esposito K., Siniscalchi M. i wsp.: Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care, 2004, 27, 47-52.
16. Marshal J.C., Eagleson C.A.: Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol. Metab. Clin. North. Amer., 1999, 28, 295-324.
17. Milner C., Craig J., Hussey N. i wsp.: No association between the - 308 polymorphism in the tumor necrosis factor alpha (TNF-alpha) promoter region and polycystic ovaries. Mol. Hum. Reprod., 1999, 5, 5-9.
18. Mohamed-Ali V., Goodrick S., Rawesh A. i wsp.: Subcutaneous adipose tissue releases interleukin - 6, but not tumor necrosis factor-α. J. Clin. Endocrinol. Metab., 1997, 82, 4196-4200.
19. Peral B., San Millan J., Castello R. i wsp.: Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J. Clin. Endocrinol. Metab., 2002, 87, 3977-3983.
20. Robak T.: Właściwości biologiczne kachektyny (TNF) i jej potencjalna rola w terapii. Post. Hig. Med. Dośw., 1991, 45, 281-297.
21. Rodin A., Thakkar H., Taylor N. i wsp.: Hyperandrogenism in polycystic ovary syndrome, evidence of dysregulation of 11 β-hydroxysteroid dehydrogenase. N. Engl. J. Med., 1994, 330, 460-465.
22. San Roman G.A, Magoffin D.A.: Insulin-like growth factor bindings proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. Clin. Endocrinol. Metab., 1992, 75, 1010-1016.
23. Senn J.J., Klover P.J., Nowak I.A. i wsp., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 2002, 51, 3391-3399.
24. Stephens J.M., Lee J., Pilch P.F.: Tumor necrosis factor-α-induced insulin resistance in 3T3 - L1 adipocytes is accompanied by a loss of insulin receptor substrate -1 and GLUT4 expression without a loss of insulin receptor - mediated signal transduction. J. Biol. Chem., 1997, 272, 971-976.
25. Stȩpień A., Stra̧czkowski M., Kinalska I.: Rola interleukiny-6 w powstaniu insulinooporności. Endokrynol. Pol., 2001, 52, 241-248.
26. Vicennati V., Vottero A., Friedman C. i wsp.: Hormonal regulation of interleukin-6 production in human adipocytes. Int. J. Obes. Relat. Metab. Disord., 2002, 26, 905-911.
27. Zachow R., Tash J., Terranova P.: Tumor necrosis factor-α attenuation of luteinizing hormone - stimulated androstenedione production by ovarian theca - interstitial cells: inhibition at loci within the adenosine 3′5′ monophosphate - dependent signaling pathway. Endocrinology, 1993, 133, 2269-2276.
28. Zahorska-Markiewicz B., Janowska J., Olszanecka-Glinianowicz M. i wsp.: Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int. J. Obes. Relat. Metab. Disord., 2000, 24, 1392-1395.
29. Zhang L.H., Rodriguez H., Ohno S. i wsp.: Serine phosphorylation of human P450c17 increases 17,20 - lyase activity: implication for adrenarche and the polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA, 1995, 92, 10619-10623.
30. Xita N., Georgiou I., Tsatsoulis A.: The genetic basis of polycystic ovary syndrome. Eur. J. Endocrinol., 2002, 147, 717-725.